Reverb Therapeutics Raises USD $12 Million Seed Round Financing to Harness Cytokine Signaling With its Amplify•R™ Platform
First-in-class antibody-based platform enables precision modulation of endogenous cytokines to amplify their therapeutic potential February 19, 2025 07:00 AM Eastern Standard Time VANCOUVER, British Columbia–(BUSINESS WIRE)–Reverb Therapeutics, a leader in harnessing the natural immune system…